These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 39074992)

  • 1. Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.
    Cook L; Verbrugge J; Schwantes-An TH; Schulze J; Foroud T; Hall A; Marder KS; Mata IF; Mencacci NE; Nance MA; Schwarzschild MA; Simuni T; Bressman S; Wills AM; Fernandez HH; Litvan I; Lyons KE; Shill HA; Singer C; Tropea TF; Vanegas Arroyave N; Carbonell J; Cruz Vicioso R; Katus L; Quinn JF; Hodges PD; Meng Y; Strom SP; Blauwendraat C; Lohmann K; Casaceli C; Rao SC; Ghosh Galvelis K; Naito A; Beck JC; Alcalay RN
    Brain; 2024 Aug; 147(8):2668-2679. PubMed ID: 39074992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.
    Westenberger A; Skrahina V; Usnich T; Beetz C; Vollstedt EJ; Laabs BH; Paul JJ; Curado F; Skobalj S; Gaber H; Olmedillas M; Bogdanovic X; Ameziane N; Schell N; Aasly JO; Afshari M; Agarwal P; Aldred J; Alonso-Frech F; Anderson R; Araújo R; Arkadir D; Avenali M; Balal M; Benizri S; Bette S; Bhatia P; Bonello M; Braga-Neto P; Brauneis S; Cardoso FEC; Cavallieri F; Classen J; Cohen L; Coletta D; Crosiers D; Cullufi P; Dashtipour K; Demirkiran M; de Carvalho Aguiar P; De Rosa A; Djaldetti R; Dogu O; Dos Santos Ghilardi MG; Eggers C; Elibol B; Ellenbogen A; Ertan S; Fabiani G; Falkenburger BH; Farrow S; Fay-Karmon T; Ferencz GJ; Fonoff ET; Fragoso YD; Genç G; Gorospe A; Grandas F; Gruber D; Gudesblatt M; Gurevich T; Hagenah J; Hanagasi HA; Hassin-Baer S; Hauser RA; Hernández-Vara J; Herting B; Hinson VK; Hogg E; Hu MT; Hummelgen E; Hussey K; Infante J; Isaacson SH; Jauma S; Koleva-Alazeh N; Kuhlenbäumer G; Kühn A; Litvan I; López-Manzanares L; Luxmore M; Manandhar S; Marcaud V; Markopoulou K; Marras C; McKenzie M; Matarazzo M; Merello M; Mollenhauer B; Morgan JC; Mullin S; Musacchio T; Myers B; Negrotti A; Nieves A; Nitsan Z; Oskooilar N; Öztop-Çakmak Ö; Pal G; Pavese N; Percesepe A; Piccoli T; Pinto de Souza C; Prell T; Pulera M; Raw J; Reetz K; Reiner J; Rosenberg D; Ruiz-Lopez M; Ruiz Martinez J; Sammler E; Santos-Lobato BL; Saunders-Pullman R; Schlesinger I; Schofield CM; Schumacher-Schuh AF; Scott B; Sesar Á; Shafer SJ; Sheridan R; Silverdale M; Sophia R; Spitz M; Stathis P; Stocchi F; Tagliati M; Tai YF; Terwecoren A; Thonke S; Tönges L; Toschi G; Tumas V; Urban PP; Vacca L; Vandenberghe W; Valente EM; Valzania F; Vela-Desojo L; Weill C; Weise D; Wojcieszek J; Wolz M; Yahalom G; Yalcin-Cakmakli G; Zittel S; Zlotnik Y; Kandaswamy KK; Balck A; Hanssen H; Borsche M; Lange LM; Csoti I; Lohmann K; Kasten M; Brüggemann N; Rolfs A; Klein C; Bauer P
    Brain; 2024 Aug; 147(8):2652-2667. PubMed ID: 39087914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
    Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the genetic variability in Parkinson's disease from Southern Spain.
    Bandrés-Ciga S; Mencacci NE; Durán R; Barrero FJ; Escamilla-Sevilla F; Morgan S; Hehir J; Vives F; Hardy J; Pittman AM
    Neurobiol Aging; 2016 Jan; 37():210.e1-210.e5. PubMed ID: 26518746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of Parkinson disease.
    Domingo A; Klein C
    Handb Clin Neurol; 2018; 147():211-227. PubMed ID: 29325612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study.
    Tan MMX; Malek N; Lawton MA; Hubbard L; Pittman AM; Joseph T; Hehir J; Swallow DMA; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Hardy J; Wood N; Ben-Shlomo Y; Grosset DG; Williams NM; Morris HR
    Brain; 2019 Sep; 142(9):2828-2844. PubMed ID: 31324919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic study of early-onset Parkinson's disease in the Malaysian population.
    Tay YW; Tan AH; Lim JL; Lohmann K; Ibrahim KA; Abdul Aziz Z; Chin YT; Mawardi AS; Lim TT; Looi I; Chia YK; Ooi JCE; Cheah WK; Dy Closas AMF; Lit LC; Hor JW; Toh TS; Muthusamy KA; Bauer P; Skrahin V; Rolfs A; Klein C; Ahmad-Annuar A; Lim SY
    Parkinsonism Relat Disord; 2023 Jun; 111():105399. PubMed ID: 37209484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural genomic variations and Parkinson's disease.
    Bandrés-Ciga S; Ruz C; Barrero FJ; Escamilla-Sevilla F; Pelegrina J; Vives F; Duran R
    Minerva Med; 2017 Oct; 108(5):438-447. PubMed ID: 28541025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.
    Gustavsson EK; Follett J; Trinh J; Barodia SK; Real R; Liu Z; Grant-Peters M; Fox JD; Appel-Cresswell S; Stoessl AJ; Rajput A; Rajput AH; Auer R; Tilney R; Sturm M; Haack TB; Lesage S; Tesson C; Brice A; Vilariño-Güell C; Ryten M; Goldberg MS; West AB; Hu MT; Morris HR; Sharma M; Gan-Or Z; Samanci B; Lis P; Periñan MT; Amouri R; Ben Sassi S; Hentati F; ; Tonelli F; Alessi DR; Farrer MJ
    Lancet Neurol; 2024 Jun; 23(6):603-614. PubMed ID: 38614108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations.
    Camargos ST; Dornas LO; Momeni P; Lees A; Hardy J; Singleton A; Cardoso F
    Mov Disord; 2009 Apr; 24(5):662-6. PubMed ID: 19205068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2.
    Bras J; Guerreiro R; Ribeiro M; Morgadinho A; Januario C; Dias M; Calado A; Semedo C; Oliveira C; Hardy J; Singleton A
    BMC Neurol; 2008 Jan; 8():1. PubMed ID: 18211709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson's patients and genotype-phenotype correlations.
    Erer S; Egeli U; Zarifoglu M; Tezcan G; Cecener G; Tunca B; Ak S; Demirdogen E; Kenangil G; Kaleagası H; Dogu O; Saka E; Elibol B
    Clin Neurol Neurosurg; 2016 Sep; 148():147-53. PubMed ID: 27455133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's Disease is Predominantly a Genetic Disease.
    Lim SY; Klein C
    J Parkinsons Dis; 2024; 14(3):467-482. PubMed ID: 38552119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of LRRK2 and SNCA in autosomal dominant Parkinson's disease in Turkey.
    Kessler C; Atasu B; Hanagasi H; Simón-Sánchez J; Hauser AK; Pak M; Bilgic B; Erginel-Unaltuna N; Gurvit H; Gasser T; Lohmann E
    Parkinsonism Relat Disord; 2018 Mar; 48():34-39. PubMed ID: 29248340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia.
    Mellick GD; Siebert GA; Funayama M; Buchanan DD; Li Y; Imamichi Y; Yoshino H; Silburn PA; Hattori N
    Parkinsonism Relat Disord; 2009 Feb; 15(2):105-9. PubMed ID: 18486522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular genetic findings of hereditary Parkinson's patients from Turkey.
    Emekli I; Tepgeç F; Samancı B; Toksoy G; Hasanoğulları Kına G; Tüfekçioğlu Z; Başaran S; Bilgiç B; Gürvit IH; Emre M; Uyguner ZO; Hanagasi HA
    Parkinsonism Relat Disord; 2021 Dec; 93():35-39. PubMed ID: 34781237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study.
    Trinh J; Gustavsson EK; Vilariño-Güell C; Bortnick S; Latourelle J; McKenzie MB; Tu CS; Nosova E; Khinda J; Milnerwood A; Lesage S; Brice A; Tazir M; Aasly JO; Parkkinen L; Haytural H; Foroud T; Myers RH; Sassi SB; Hentati E; Nabli F; Farhat E; Amouri R; Hentati F; Farrer MJ
    Lancet Neurol; 2016 Nov; 15(12):1248-1256. PubMed ID: 27692902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical genetics of Parkinson's disease and related disorders.
    Wider C; Wszolek ZK
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S229-32. PubMed ID: 18267241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.